Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    18402537 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Terminated Alternative in Beta Blocker Intolerance: The ABBI Trial
Condition: Coronary Artery Disease
Intervention: Drug: Nebivolol

Study has passed its completion date and status has not been verified in more than two years.